MMP9:神经病变与结直肠癌之间的联系?
Cynthia Rosa Regalado1, Mihály Balogh1
1Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, Netherlands.
Frontiers in molecular biosciences
|December 12, 2024
概括
矩阵金属蛋白酶9 (MMP9) 可能在接受化疗的结直肠癌 (CRC) 患者中驱动神经损伤. 了解MMP9在CRC和化疗诱导的周围神经病变 (CIPN) 中的作用,可能会揭示新的治疗点.
科学领域:
- 在瘤学瘤学.
- 神经科学是一个神经科学.
- 生物化学 生物化学
背景情况:
- 结肠直肠癌 (CRC) 治疗严重依赖于化疗,但化疗诱导的周围神经病变 (CIPN) 在约30%的患者中引起慢性,无法治疗的疼痛.
- 尽管癌症神经科学领域的兴趣越来越大,但难以治疗的CIPN的风险因素仍然基本上是未知的.
- 矩阵金属蛋白酶9 (MMP9) 涉及CRC进展和神经病变,这表明这些疾病之间存在潜在的联系.
研究的目的:
- 审查MMP9在CRC和神经病变之间的联系中的作用.
- 探索CRC和CIPN之间共享的病理生理机制.
- 确定MMP9作为缓解CRC患者CIPN的潜在治疗标.
主要方法:
- 系统审查过去20年发表的研究.
- 对MMP9参与CRC进展和CIPN.的见解的综合.
- 对相互连接的途径的分析,包括ECM重塑,炎症和巨细胞调节.
主要成果:
- MMP9是细胞外基质 (ECM) 重塑,炎症和信号传导途径的关键调解者.
- 巨细胞调节MMP9的活动,突出显示了它在瘤微环境中的作用.
- 涉及MMP9的共享机制表明它对CRC患者的神经病变的贡献.
结论:
- MMP9是CRC进展的关键因素,可能导致神经元损伤,导致慢性CIPN.
- 向MMP9是一个有前途的治疗策略,用于控制CRC患者的CIPN症状.
- 需要进一步的纵向研究来证实MMP9对神经病症结果的影响,并开发向的MMP9抑制剂.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K